GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility. Researchers stress the need for independent studies before these treatments can be fully embraced worldwide.
source https://www.sciencedaily.com/releases/2025/11/251116105627.htm
No comments:
Post a Comment